Pompe Disease Clinical Trials

A listing of Pompe Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 56 clinical trials
Multicenter Clinical Study of the SING-IMT in Patients With Late-stage AMD (CONCERTO)

central vision loss due to late-stage age-related macular degeneration (AMD).

  • 7 views
  • 04 Oct, 2022
  • 2 locations
Retinal Imaging Using NOTAL-OCT V3.0

The study will include up to 250 AMD patients and up to 30 DR patients. In Tel Aviv medical center up to 100 AMD/ 20 DR patients will be recruited; In Assuta HaShalom up to 100 AMD/10 DR

edema
  • 5 views
  • 04 Oct, 2022
  • 2 locations
The Implementation of Educational Interventions on the Prescribing of Antimicrobial Drugs in Primary Health Care

World increase in mortality from consequences of antimicrobial resistance (AMR) represents a significant public health problem. Irrational prescribing of antimicrobial drugs (AMD) in general

antimicrobials
antibiotics
Accepts healthy volunteers
  • 0 views
  • 04 Oct, 2022
  • 1 location
Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER). (TIGER)

called wet age-related macular degeneration (AMD), where new abnormal blood vessels grow through the macula and leak fluid. This can affect vision. In some cases, wet AMD can also cause a bleed under the

  • 0 views
  • 04 Oct, 2022
  • 14 locations
A Phase 1b Multicenter, Randomized, Controlled, Single-dose Study of the Safety and Tolerability of ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy (GA) Associated With Age-related Macular Degeneration (AMD

The purpose of this study is to evaluate the safety and tolerability of intravitreal injection of ONL1204 Ophthalmic Solution in patients with geographic atrophy associated with AMD

geographic atrophy
ophthalmic solution
neovascularization
detachment
fundus autofluorescence imaging
  • 5 views
  • 22 Oct, 2022
  • 4 locations
A Twelve-Month, Randomized, Double-Masked, Multicenter, Phase III, Two-Arm Study Comparing the Efficacy and Safety of Brolucizumab 6 mg Versus Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

To compare brolucizumab to aflibercept in Chinese patients with untreated active choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD)

neovascularization
aflibercept
age-related macular degeneration
brolucizumab
  • 2 views
  • 10 Oct, 2022
  • 17 locations
Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT) (i-SIGHT)

Evaluate the safety and efficacy of transpalpebral microcurrent stimulation (MCS) therapy for patients with nonexudative (dry) age-related macular degeneration (AMD).

  • 0 views
  • 07 Oct, 2022
  • 3 locations
  • 0 views
  • 17 Oct, 2022
  • 3 locations
Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration (FALCON)

(AMD) who have previously received anti-VEGF (vascular endothelial growth factor) treatment.

growth factor
corrected visual acuity
retinopathy
retinal pigment
spectral domain optical coherence tomography
  • 0 views
  • 04 Oct, 2022
  • 29 locations
A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Intravitreal Injections of FHTR2163 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD) who completed the parent study (NCT03972709/GR40973).

corrected visual acuity
geographic atrophy
atrophy
  • 63 views
  • 16 Sep, 2022
  • 49 locations